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We have investigated heeffect of the b isoform of S-100 proteins on adenylate cyclase activity of rat skeletal muscle. 
S-1OOb inhibits the adenylate cyclase activity in the presence of Mg2+ (X1-50 mM), while it activates the same enzyme 
in the presence of CP+ (0. l-l .O mM) dose-dependently in both cases. S-1OOb counteracts the stimulatory effect of NaF 
on adenylate cyclase in the presence of M$+ and the inhibitory effect of RMI 12330 A in the presence of Ca*+. 
Protein S- 100; Adenylate cyclase; (Skeletal muscle) 
1. INTRODUCTION 
It is well established that the activity of adenylate 
cyclase (ATP pyrophosphate lyase cyclizing EC 
4.6.1.1) is modulated by membrane proteins such 
as the G-proteins [l-5] as well as by cytoplasmic 
proteins. Among the latter, the ubiquitous intra- 
cellular Ca’+-binding protein, calmodulin, has 
been shown to regulate a particular (calmodulin- 
sensitive) adenylate cyclase activity in the brain and 
other tissues [6,7]. Calmodulin stimulates the 
adenylate cyclase activity by interacting directly 
with the catalytic component of the enzyme [8]. 
A group of three 21 kDa, acidic, Ca’+-binding 
proteins known as S-100 belongs to the family of 
Ca2+-modulated, EF hand-type polypeptides that 
are structurally related to calmodulin and other 
acidic Ca’+-binding proteins (see [9] for a recent 
review). S-100 is present in many cell types, 
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although individual S-100 isoforms (S-lOOa,.,, 
S-100a and S-1OOb) are differently distributed in 
cells [g-13]. S-100 proteins have been shown to 
regulate a number of kinase and phosphoprotein 
phosphatase activities [ 141, a brain aldolase activity 
[15] and the process of microtubule assembly- 
disassembly [16] in vitro. Some of these effects are 
strictly Ca2+-dependent, while others are not. 
More recently, the human gene encoding the ,& 
subunit of S-100 has been located on chromosome 
21 and this has been related to some neurological 
aspects of Down syndrome [ 171. 
In view of the structural similarity of S-100 to 
calmodulin, we sought to investigate the effects of 
S-1OOb protein on adenylate cyclase activity of rat 
skeletal muscle. The results indicate that S-100b in- 
hibits the adenylate cyclase activity in the presence 
of Mg2+ and increases this activity in the presence 
of Ca’+. Both effects are obtained using a concen- 
tration of S-1OOb in the range 0.05-5 PM. 
2. EXPERIMENTAL 
S-1OOb was purified from rat brain and characterized as 
described [18]. TRK 432 CAMP assay kit was obtained from the 
radiochemical Center (Amersham, England). ATP, GTP, DTT 
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and BSA were from Sigma (St. Louis, MO). RMI 12330 A [N- 
(cis-2-phenylcyclopentyl)-azacyclotridecan-2-imine hydro- 
chloride] was a generous gift from Dr C. Biondi (Istituto di 
Fisiologia Generale, Universita di Ferrara, Italy). 
Skeletal muscles from adult rat legs were used. Samples (10 g) 
were minced, and homogenized in 50 mM Tris-maleate (pH 7.4) 
containing 2 mM EGTA. The homogenate was filtered through 
four layers of cheese-cloth and the residue resuspended in the 
same buffer at a final protein concentration of 2.5 mg/ml. The 
suspension was immediately used for the adenylate cyclase assay 
[19]. The assay medium (pH 7.4) consisted of the following 
(final concentrations): 50 mM Tris-acetate, 5 mM Teophylline, 
5 mM DTT, 0.5 mg/ml BSA, 0.05 mM GTP (in some ex- 
periments 0.5 mM), 50-200 fig muscle proteins and Hz0 to a 
final volume of 0.5 ml. After 5 min of incubation at 4°C the 
test substances (S-lOOb, RMI, NaF) were added to the final con- 
centrations reported in the figure and table legends. The incuba- 
tion was continued for 10 min at 4°C then the reaction was 
started by adding 5 mM ATP and Me’+ (Mg’+ or Ca2+), and 
continued during the next 10 min at 37°C in a shaking water 
bath. The reaction was stopped by boiling for 5 min. The 
samples were stored at 4°C overnight and microfuged (18000 x 
g x 5 min) for precipitation of denatured proteins. The super- 
natants were collected and the CAMP determination was carried 
out by a displacement binding assay using a commercial kit. 
Protein was measured by the method of Lowry et al. against a 
standard solution of BSA [20]. 
3. RESULTS 
Adenylate cyclase is weakly active in the absence 
of divalent cations such as Mg’+, Ca2+ or Mn2+. A 
crude preparation of the enzyme obtained from rat 
skeletal muscle has an activity of 6.5 pmol CAMP 
produced/mg protein per min (table 1). 5 mM 
Mg2+ increases this activity to a maximum of 165.6 
pmol cAMP/mg protein per min with an approx- 
imate 30-fold activation (table 1). 
Under these conditions, S-100b (5 PM) causes a 
reduction in the Mg2+ -activated activity to 20% of 
Table 1 
Effect of 5 gM S-1OOb on adenylate cyclase activity in the 
presence of MgZf, NaF or the inhibitor RMI 
- S-1OOb + S-1OOb 
None 6.5 * 0.3 5.2 f 0.2 
5 mM Mg2+ 165.6 f 14.2 46.2 + 2.1 
50 mM Mg2+ 241.3 f 27.1 161.8 * 14.7 
5 mM Mg’+/l mM NaF 235.2 f 31.0 145.7 + 16.3 
5 mM Mgzt/l mM RMI 12.8 f 7.4 14.6 & 5.8 
The values are expressed as pmol/min per mg and represent he 
mean f SD of nine measurements 
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Fig.1. Effect of different concentrations of S-100b (0.05-5.0 
PM) on adenylate cyclase activity measured in the presence of 5 
mM MgZf. The data given refer to one of four experiments 
(mean f SD, n=5). 
that detectable in the presence of Mg2+ alone (table 
1). 
In a total of five experiments performed with 
three different enzyme preparations, the inhibition 
exerted by 5 PM S-1OOb ranged between 70 and 
80%. At 5 mM Mg2+ the inhibitory effect is dose- 
dependent and half-maximal between 0.05 and 0.5 
PM S-1OOb (fig.1). 
In a preliminary attempt o elucidate the mode of 
action of S-lOOb, we tested its effect in the presence 
of two substances known to activate (NaF) [21] or 
to inhibit (RMI) [22] adenylate cyclase. These 
substances have been shown to act on the in- 
Table 2 
Effect of 5 pM S-1OOb on adenylate cyclase in the presence of 
Ca2+ and RMI 
- S-1OOb + S-1OOb 
None 4.9 + 0.2 4.6 f 0.1 
0.1 mM Ca2+ 57.6 + 14.9 107.0 * 13.4 
1 .O mM Ca2+ 57.0 + 10.8 104.0 * 13.1 
1.0 mM Ca’+/l.O mM RMI 16.8 + 6.5 35.4 * 7.0 
The activity is expressed as pmol/min per mg and it is referred 
to mean + SD of eleven measurements 
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Fig.2. Activating effect of S-1oOb (0.05S.OpM) measured in the 
presence of 1 mM Ca’*, on adenylate cyclase activity. Data 
reported are from one of three experiments carried out in 
quadruplicate. 
termediate component of the enzyme complex. 
S-1OOb blocks the activating action of NaF and 
maintains the activity at the level detected when the 
enzyme is assayed without F- (table 1). On the 
other hand, S-1OOb does not alter the inhibitory ac- 
tivity exerted by RMI (table 1). 
Adenylate cyclase is also markedly stimulated by 
Ca2+ which shifts the activity from a basal level of 
4.9-57.6 pmol/min per mg (table 2). S-1OOb (5pM) 
increases the activating effect of Ca2+ by 100% 
(table 2) with a half-maximal effect between 0.05 
and 0.5 PM (fig. 2). Since S-1OOb alone has no ac- 
tivating effect (tables 1 and 2), we conclude that 
S-1OOb amplifies the Ca2+ signal at the concentra- 
tions used in our assay. 
Finally, RMI reduces the Ca2+-dependent activa- 
tion of adenylate cyclase (table 2), and S-IOOb 
counteracts the effect of this inhibitor (table 2). 
Results very similar to those reported here are ob- 
tained with purified sarcolemma membrane 
preparations (not shown). 
4. DISCUSSION 
The data presented in this report show that 
S-1OOb can modulate the activity of adenylate 
cyclase by markedly decreasing the activating ac- 
tion of Mg2+ and by increasing the stimulating ef- 
fect of Ca’+. 
As to the S-1OOb effect in the presence of Ca2+, 
it is noteworthy that the protein is equally effective 
at 0.1 mM Ca2+ as at 1 mM Ca2+. The affinity of 
S-100 proteins for Ca2+ in the absence of 
monovalent cations is 0.05 mM [23]. Thus the abili- 
ty of S-1OOb to regulate muscle adenylate cyclase 
may be achieved via conformational changes in- 
duced on it by Ca2+ at 0.1-1.0 mM [24]. 
Recent observations indicate that the affinity of 
S-1OOb protein for Ca2+ depends on its conforma- 
tion and increases once this protein has interacted 
with its targets [25,26]. The findings registered in 
the presence of Mg2+ or a combination of this 
cation with RMI or NaF deserve some comments. 
The effect of S-100b in the presence of Mg2+ can- 
not be attributed to chelation of Mg2+ since this 
cation is present in large excess over S-100b and 
since this protein does not appreciably bind Mg2+ 
v71. 
An attractive possibility is that S-100b 
counteracts the activating effect of Mg2+ by a 
direct interaction with some component(s) of the 
enzyme system. This conclusion is further 
strengthened by the finding that S-1OOb abolishes 
the activating effect of NaF which has been shown 
to affect the intermediate fraction of adenylate 
cyclase [21]. This hypothesis could be confirmed by 
experimental tests with the use of labeled S-IOOb 
and identification of protein components of the 
adenylate cyclase system with which S-1OOb in- 
teracts. Future studies should allow one to dissect 
the molecular mechanism involved in the opposite 
effects exerted by S-IOOb on adenylate cyclase 
depending on the metal present and, most impor- 
tant, whether the protein is also effective on this 
enzymatic system in an intact cell. 
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